Equity to Asset ratio is calculated as total stockholders equity divided by total asset. ResMed's Total Stockholders Equity for the quarter that ended in Dec. 2023 was $4,482 Mil. ResMed's Total Assets for the quarter that ended in Dec. 2023 was $6,905 Mil.
Therefore, ResMed's Equity to Asset Ratio for the quarter that ended in Dec. 2023 was 0.65.
The historical rank and industry rank for ResMed's Equity-to-Asset or its related term are showing as below:
RMD'
s Equity-to-Asset Range Over the Past 10 Years
Min: 0.49 Med: 0.61 Max: 0.75
Current: 0.65
During the past 13 years, the highest Equity to Asset Ratio of ResMed was 0.75. The lowest was 0.49. And the median was 0.61.
RMD's Equity-to-Asset is ranked better than 50.34% of 870
companies
in the Medical Devices & Instruments industry
Industry Median: 0.65
vs RMD: 0.65
ResMed Equity-to-Asset Historical Data
The historical data trend for ResMed's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of ResMed's Equity-to-Asset
For the Medical Instruments & Supplies subindustry, ResMed's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ResMed's Equity-to-Asset Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, ResMed's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where ResMed's Equity-to-Asset falls into.
ResMed Equity-to-Asset Calculation
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
ResMed's Equity to Asset Ratio for the fiscal year that ended in Jun. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ResMed (NYSE:RMD) Equity-to-Asset Explanation
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
ResMed Equity-to-Asset Related Terms
Thank you for viewing the detailed overview of ResMed's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
RMD has been successfully added to your 